Johnson & Johnson »

Rapport Therapeutics shares owned by Johnson & Johnson

Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Johnson & Johnson from 13F filings

Historical chart of Johnson & Johnson investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Johnson & Johnson

Quarter filed Position value Share count Share price at filing
2024-06-30 $58M 2.5M 23.26